Inhibitory activities of benzoaxol derivatives on mammalian type I DNA topoisomerase

被引：0
|
作者：
Soyer, Z.
Kocadag, E.
Pabuccuoglu, V.
Telefoncu, A.
Topçu, Z.
机构：
[1] Ege Univ, Dept Pharmaceut Chem, Fac Pharm, Izmir, Turkey
[2] Ege Univ, Dept Biochem, Fac Sci, Izmir, Turkey
[3] Ege Univ, Dept Pharmaceut Biotechnol, Fac Sci, Izmir, Turkey
来源：
FEBS JOURNAL | 2006年 / 273卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
PP434
引用
收藏
页码：193 / 194
页数：2
相关论文
共 50 条
  • [21] Synthesis of rotenoid derivatives with cytotoxic and topoisomerase II inhibitory activities
    Sangthong, Supranee
    Krusong, Kuakarun
    Ngamrojanavanich, Nattaya
    Vilaivan, Tirayut
    Puthong, Songchan
    Chandchawan, Supajittra
    Muangsin, Nongnuj
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (16) : 4813 - 4818
  • [22] Evaluation of DNA Binding and Topoisomerase I Inhibitory Activities of 16′-Decarbomethoxydihydrovoacamine from Tabernaemontana corymbosa
    Tan, Chun Hoe
    Sim, Dawn Su Yin
    Heng, Mok Piew
    Lim, Siew Huah
    Low, Yun Yee
    Kam, Toh Seok
    Sim, Kae Shin
    CHEMISTRYSELECT, 2020, 5 (47): : 14839 - 14843
  • [23] MAMMALIAN MITOCHONDRIAL-DNA TOPOISOMERASE-I
    CASTORA, FJ
    HENRICH, JP
    KELLY, WG
    LAZARUS, GM
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1986, : 148 - 148
  • [24] Inhibitory effect of conjugated eicosapentaenoic acid on mammalian DNA polymerase and topoisomerase activities and human cancer cell proliferation
    Yonezawa, Y
    Hada, T
    Uryu, K
    Tsuzuki, T
    Eitsuka, T
    Miyazawa, T
    Murakami-Nakai, C
    Yoshida, H
    Mizushina, Y
    BIOCHEMICAL PHARMACOLOGY, 2005, 70 (03) : 453 - 460
  • [25] A type IB topoisomerase with DNA repair activities
    Belova, GI
    Prasad, R
    Kozyavkin, SA
    Lake, JA
    Wilson, SH
    Slesarev, AI
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (11) : 6015 - 6020
  • [26] Semi-synthesis, topoisomerase I and kinases inhibitory properties, and antiproliferative activities of new rebeccamycin derivatives
    Moreau, P
    Gaillard, N
    Marminon, C
    Anizon, F
    Dias, N
    Baldeyrou, B
    Bailly, C
    Pierré, A
    Hickman, J
    Pfeiffer, B
    Renard, P
    Prudhomme, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (23) : 4871 - 4879
  • [27] Inhibitory activities against, topoisomerase I & II by polyhydroxybenzoyl amide derivatives and their structure-activity relationship
    Abdel-Aziz, M
    Matsuda, K
    Otsuka, M
    Uyeda, M
    Okawara, T
    Suzuki, K
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (07) : 1669 - 1672
  • [28] BN 80927: A novel homocamptothecin with inhibitory activities on both topoisomerase I and topoisomerase II
    Lavergne, O
    Harnett, J
    Rolland, A
    Lanco, C
    Lesueur-Ginot, L
    Demarquay, D
    Huchet, M
    Coulomb, H
    Bigg, DCH
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (17) : 2599 - 2602
  • [29] Effects of uracil incorporation, DNA mismatches, and abasic sites on cleavage and religation activities of mammalian topoisomerase I
    Pourquier, P
    Ueng, LM
    Kohlhagen, G
    Mazumder, A
    Gupta, M
    Kohn, KW
    Pommier, Y
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (12) : 7792 - 7796
  • [30] SYNTHESIS AND KINETIC EVALUATION OF 1H-BENZIMIDAZOLE DERIVATIVES AS MAMMALIAN DNA TOPOISOMERASE I INHIBITORS
    Zencir, Sevil
    Alpan, Selcen A.
    Alcil, Pinar
    Coban, Gunes
    Gunes, Semih
    Topcu, Zeki
    DRUG METABOLISM REVIEWS, 2007, 39 : 220 - 220
12345